Scalable patient-centered team care for adults with type 2 diabetes
Implementing Scalable, PAtient-centered Team-based Care for Adults with Type 2 Diabetes and Health Disparities (iPATH)
This project will refine and spread a team-based care program to help adults with type 2 diabetes get better blood sugar control at community health centers.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11259581 on NIH RePORTER |
What this research studies
If you get care at a participating federally qualified health center (FQHC), the research team from Stanford, Harvard, Ohio State, and a partner will work with your clinic to refine and deliver a team-based, patient-centered diabetes care approach. They will conduct 12 in-depth regional case studies comparing clinics that perform well versus those that do not, and use rapid data collection and reporting to identify practical changes clinics can make. The team will implement the approach across participating clinics and track diabetes outcomes such as A1c and care processes. A prior pilot of this approach showed an average 31% reduction in the proportion of patients with A1c over 9%, and this project aims to reproduce and scale those gains.
Who could benefit from this research
Good fit: Adults (age 21 and over) with type 2 diabetes who receive care at participating federally qualified health centers are the intended candidates.
Not a fit: People who do not receive care at participating FQHCs, children, or people with type 1 diabetes are unlikely to benefit directly from this project.
Why it matters
Potential benefit: If successful, this could help community clinic patients achieve better blood sugar control and reduce diabetes-related complications.
How similar studies have performed: A prior pilot of this implementation approach reported a 31% average reduction in poorly controlled A1c, and other team-based care programs have also shown improved diabetes outcomes.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Singer, Sara Jean — Stanford University
- Study coordinator: Singer, Sara Jean
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.